News

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. We identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture of the latest advancements spanning diverse therapeutic areas and key development phases.

Proteins, Antibodies & ADCs

Zymeworks Granted IND Clearance for Novel ADC, ZW251

Multiple Myeloma mRNA Cancer Vaccine Slows Tumour Growth in Mice

Promising Phase I Results from Osteoarthritis Gene Therapy

Scientists Find ‘Virtual Memory T Cells’, a Critical Component of Infant Immunity

TandemAI and Perpetual Medicines Merge to Form New Small Molecule and Peptide Discovery

In Vivo CAR T Proven Effective and Safe in Mice, says Stanford Study

Biologics US 2025 and Cell UK 2025: Uniting Innovation Across Biologics and Advanced Therapies

Promising Results from Phase II Neoantigen Peptide Vaccine Trial with CLERT

Proteins, Antibodies & ADCs

Intranasal mAbs Act as ‘Molecular Shield’ Against Pollen in Potential Hay Fever Treatment

Potential ‘Universal Cancer Vaccine’ Tested by Florida Researchers in Mice

AAV Gene Therapy Restores Hearing in Deaf Patients

World’s First Recombinant Anthrax Vaccine Developed in Korea

Proteins, Antibodies & ADCs

Akeso’s First Bispecific ADC Enters the Clinic

‘Anti-Aging Vaccine’ Shows Promising Results in Mice

Invivyd’s New mAb for COVID Ticks Safety and PK in Phase I/II

Idorsia Targets Bacteria with New Synthetic Glycan Vaccine Platform

Sangamo to Seek Approval for Fabry Disease Gene Therapy After Phase I/II Results

Paper Suggests Vaccine Type and Patient Sex Linked to COVID T-cell Response

Could an In Vivo CAR T Approach be Applied to Autoimmune Diseases? AbbVie Buys Capstan Tx

Proteins, Antibodies & ADCs

Designing the Future: AI Meets Antibody Engineering

Lung-Targeted Delivery System for Gene Therapies Treats Cancer and Cystic Fibrosis

Proteins, Antibodies & ADCs

UCB Plans $5 Billion Manufacturing Investment to Boost Biologics Capacity